Literature DB >> 28528689

Human papillomaviruses in epigenetic regulations.

Julia Durzynska1, Krzysztof Lesniewicz2, Elzbieta Poreba3.   

Abstract

Human Papillomaviruses (HPVs) are double-stranded DNA viruses, that infect epithelial cells and are etiologically involved in the development of human cancer. Today, over 200 types of human papillomaviruses are known. They are divided into low-risk and high-risk HPVs depending on their potential to induce carcinogenesis, driven by two major viral oncoproteins, E6 and E7. By interacting with cellular partners, these proteins are involved in interdependent viral and cell cycles in stratified differentiating epithelium, and concomitantly induce epigenetic changes in infected cells and those undergoing malignant transformation. E6 and E7 oncoproteins interact with and/or modulate expression of many proteins involved in epigenetic regulation, including DNA methyltransferases, histone-modifying enzymes and subunits of chromatin remodeling complexes, thereby influencing host cell transcription program. Furthermore, HPV oncoproteins modulate expression of cellular micro RNAs. Most of these epigenetic actions in a complex dynamic interplay participate in the maintenance of persistent infection, cell transformation, and development of invasive cancer by a considerable deregulation of tumor suppressor and oncogenes. In this study, we have undertaken to discuss a number of studies concerning epigenetic regulations in HPV-dependent cells and to focus on those that have biological relevance to cancer progression.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; DNA methylation; Epigenetic regulation; Histone modification; Human papillomavirus; Micro-RNAs

Mesh:

Substances:

Year:  2016        PMID: 28528689     DOI: 10.1016/j.mrrev.2016.09.006

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  38 in total

1.  Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205.

Authors:  Li-Guo Zhang; Xin-Ke Zhou; Ru-Jian Zhou; Hui-Zeng Lv; Wei-Peng Li
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Authors:  Sunny Haft; Shuling Ren; Guorong Xu; Adam Mark; Kathleen Fisch; Theresa W Guo; Zubair Khan; John Pang; Mizuo Ando; Chao Liu; Akihiro Sakai; Takahito Fukusumi; Joseph A Califano
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

3.  Awareness of HPV and Cervical Cancer Prevention Among University Health Sciences Students in Cyprus.

Authors:  Paraskevi A Farazi; Mohammad Siahpush; Tzeyu L Michaud; Jungyoon Kim; Chenai Muchena
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

4.  EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.

Authors:  Ting Lei; Xiaodong Zhu; Kai Zhu; Fuxin Jia; Siqiao Li
Journal:  Cancer Biol Ther       Date:  2019-03-31       Impact factor: 4.742

5.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

6.  Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.

Authors:  Irene Lo Cigno; Federica Calati; Cinzia Borgogna; Alessandra Zevini; Silvia Albertini; Licia Martuscelli; Marco De Andrea; John Hiscott; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

7.  Lysine-specific post-translational modifications of proteins in the life cycle of viruses.

Authors:  Anna P Loboda; Surinder M Soond; Mauro Piacentini; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 4.534

Review 8.  The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases.

Authors:  Ning Ding; Ashley R Maiuri; Heather M O'Hagan
Journal:  Mutat Res Rev Mutat Res       Date:  2017-09-28       Impact factor: 5.657

9.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

10.  DNA hypermethylation during tuberculosis dampens host immune responsiveness.

Authors:  Andrew R DiNardo; Kimal Rajapakshe; Tomoki Nishiguchi; Sandra L Grimm; Godwin Mtetwa; Qiniso Dlamini; Jaqueline Kahari; Sanjana Mahapatra; Alexander Kay; Gugu Maphalala; Emily M Mace; George Makedonas; Jeffrey D Cirillo; Mihai G Netea; Reinout van Crevel; Cristian Coarfa; Anna M Mandalakas
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.